Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sjurdur Frodi Olsen
With
Copenhagen University Hospital, Rigshospitalet
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
The low dose (prophylactic) section enrolled women who after 16 weeks of gestation had been identified with an uncomplicated pregnancy, who in an earlier pregnancy had experienced preterm delivery (this was subgroup 1)
Women who had been identified with twin pregnancies (subgroup 4)
The high dose ('therapeutic') section enrolled women with threatening pre-eclampsia (subgroup 5) or suspected intrauterine growth retardation in the current pregnancy (subgroup 6).
You may not be if
Diabetes mellitus in or before pregnancy
Diagnosed severe fetal malformation or hydrops in current pregnancy
Suspicion in current pregnancy, or occurrence in an earlier pregnancy, of placental abruption
Drug or alcohol abuse
Regular intake of fish oil or of non-steroidal antiinflammatory agents or other drugs with an effect on thombocyte function or eicosanoid metabolism
Allergy to fish products.
Clareo Health | Fish Oil Trials in Pregnancy for the Prevention of Pregnancy Complications ('FOTIP')
